See also
Poisoning - Acute guidelines for initial management
Use of activated charcoal in poisonings
Serotonin toxicity
Anticholinergic Syndrome
Febrile Seizures
Key points
- TCA poisoning can be fatal in
relatively low doses
- Its serious effects include
Cardiac instability including arrhythmias and reduced cardiac contractility and
neurological instability including CNS depression and seizures
- Management is mainly supportive but
alkalinisation with Sodium Bicarbonate may be needed
For 24 hour advice, contact the Victorian Poisons Information Centre on 13 11 26
Background
Tricyclic antidepressants
(TCA) are one of the common causes of a fatal drug overdose. They have a narrow
therapeutic window so can be fatal at relatively lower doses and single tablet
fatalities have been reported. Its most serious effects are cardiovascular and CNS
instability. Patients have the potential to deteriorate quickly. Most poisoning
presentations are from an acute ingestion; however chronic poisoning can also present
acutely.
Tricyclic Antidepressants
have their toxic effects through action at 4 main receptors involving
antagonism/inhibition at:
- Central and peripheral acetylcholine
receptors
- α adrenergic receptors
peripherally
- Noradrenalin and serotonin reuptake
- Fast sodium channels in
myocardial cells
Tricyclic antidepressants
- Amitriptyline
- Imipramine
- Nortriptyline
- Doxepin
- Dothiepin
- Clomipramine
Pharmacokinetics
- Onset: Signs usually
within an hour of ingestion and most within 6 hours, however can have unpredictable
absorption and half-life due to the anticholinergic effect causing delayed
gastrointestinal transit time
- Following initial
metabolism in the liver, TCA metabolites are renally excreted. Some metabolites
have pharmacological activity equal to that of the parent drug eg. Desipramine,
metabolite of imipramine
If TCA poisoning is suspected, please seek
senior advice and discuss with a toxicologist.
Patients requiring assessment
-
All patients with deliberate
self-poisoning
- Any symptomatic patient
- Asymptomatic patients with
underlying cardiac or neurological disease
- Doses >5 mg/kg in
children should be referred to hospital
- Patients with Doses >10-15 mg/kg
should be intubated, ventilated and be given charcoal
- Any
patient whose developmental age is inconsistent with accidental poisoning as
non-accidental poisoning should be considered.
Risk Assessment
History
- Intentional
or accidental overdose
- Amount
ingested
- Time
of ingestion
- Co-ingestants
eg. Serotonin reuptake inhibitors may increase tricyclic levels in plasma and
precipitate serotonin syndrome
Exam
Symptoms based on toxidrome:
- Myocardial Sodium channel antagonism:
Reduced cardiac contractility and hypotension, widened QRS predisposing to VT
and VF, Prolonged QT
- Inhibition of noradrenalin and
serotonin reuptake: CNS depression/coma, seizures
- Anticholinergic: Sinus tachycardia,
Vomiting, Blurred vision, Ataxia, Delirium, Urinary retention, Ileus
- Antiadrenergic: Vasodilation
Investigations
- TCA levels useful if diagnosis in
doubt, not useful as a predictor of outcome
- ECG on admission and repeated if
abnormalities found: QRS >100ms associated with seizures, QRS>160ms associated
with ventricular arrhythmias
- Paracetamol level in case of
co-ingestion
- Glucose level if reduced GCS
- Blood gas looking for acidosis
Acute Management
No
antidote, treatment is supportive
1. Resuscitation
Standard procedures and supportive care.
Consider intubation early in reduced GCS.
2. Decontamination
Charcoal is generally contraindicated
due to risk of aspiration however patients with ingestion of doses >10-15 mg/kg
should be given charcoal following intubation
3. Specific Treatments
If QRS widened or Ventricular arrhythmia, commence alkalization with Sodium Bicarbonate bolus 2 mmol/kg. Repeat boluses may be given in addition to consideration
to intubation and hyperventilation to optimise pH to 7.5.
Ongoing care and monitoring
- Cardiac monitoring and regular ECGs
- If altered conscious state, GCS
<12, seizures, widened QRS or arrhythmia, contact ICU
- Treat seizures with benzodiazepines, avoid
phenytoin as it has sodium channel blockade activity
- If Asymptomatic: Investigations as
above, observe for 6 hours and discharge if ECG remains normal
When to admit/consult local
paediatric team, or who/when to phone
Admission should be
considered for
- all adolescent patients
with an intentional overdose,
- symptomatic patients
- those with an overdose in
the presence of cardiovascular or neurological disease
- those with co-ingestion of
cardio depressant medications or MAO inhibitors.
Patients with an
intentional overdose should have a mental health review.
Contact Victorian Poisons Information Centre
13 11 26 for advice
When to consider transfer to a
tertiary centre
Patient with significant
CNS depression/seizures or any cardiovascular instability.
Patient requiring
care beyond the comfort level of the current hospital
For emergency advice and paediatric or neonatal ICU transfers, call the Paediatric Infant Perinatal Emergency Retrieval (PIPER) Service: 1300 137 650.
Discharge Criteria
Normal GCS
Normal ECG
Period of observation for 6 hours if stable
For deliberate ingestion, a risk assessment should indicate that
the patient is at low risk of further self-harm in the discharge setting
Discharge information and
follow-up
Accidental ingestion: Parent information sheet from Victorian Poisons Information centre
on the prevention of poisoning
Intentional
self-harm: Referral to local mental health services e.g. Orygen Youth
Health: 1800 888 320
Recreational poisoning: Referral
to YoDAA,
Victoria's Youth Drug and Alcohol Advice service: 1800 458
685
Last updated June 2017